Skip to main content

Ikarian Capital, LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1778253 DALLAS, TX

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,627,591
-$843,952 QoQ
Shares Held
293,258
-49.1% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Derivatives in VIR

reported options exposure · as of Dec 31, 2024
CallValue
$5,287,002
CallShares
720,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $653,059,812 across 106 Biotechnology names. VIR ranks #52 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VIR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,627,591 293,258
2025-12-31 $3,471,543 575,712
2025-09-30 $3,388,165 593,374
2025-06-30 $5,383,032 1,068,062
2025-03-31 $6,921,041 1,068,062
2024-12-31 $5,287,002 720,300
2024-12-31 $6,590,307 897,862
2021-03-31 $12,817,500 250,000
2020-12-31 $7,177,040 268,000